Effects of chronic alcohol consumption on lipid levels, inflammatory and haemostatic factors in the general population: The ‘attica’ study

European Journal of Preventive Cardiology

Volumn 10, Issue 5, 2003, Pages 355-361

  Chrysohoou, Christina ^a   Panagiotakos, Demosthenes B ^a   Pitsavos, Christos ^a   Skoumas, John ^a   Toutouza, Marina ^a   Papaioannou, Ioanna ^a   Toutouzas, Pavlos K ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

alcohol; haemostatic factors; inflammation; lipids

Indexed keywords

ALCOHOL; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID DERIVATIVE;

ADULT; ALCOHOL CONSUMPTION; AMINO ACID BLOOD LEVEL; ARTERIAL PRESSURE; ARTICLE; ATHEROSCLEROSIS; BIOCHEMISTRY; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CORONARY RISK; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GREECE; HEMOSTASIS; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; LEUKOCYTE COUNT; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; FIBRINOGEN; GREECE; HEMOSTASIS; HUMANS; LEUKOCYTE COUNT; LIPIDS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDE FRAGMENTS; RISK FACTORS;

EID: 0347655018     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000065928.57001.4d     Document Type: Article

References (30)

1. Klattky A, Armstrong MA, Friedman GD. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am J Cardiol 1990; 66: 1237–1242.
2. Rimm EB, Giovannucci EL, Willett WC. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991; 338: 464–468.
3. Fumeron F, Betoulle D, Luc G, Behague I. Alcohol intake modulates the effect of a polymorphism of the cholesterol ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995; 96: 1664–1671.
4. Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 1992; 85: 910–915.
5. Mukamal KJ, Jadhan PP, De Agostino RB, Massaro JM, Mittleman MA, Lipinska I, et al Alcohol consumption and hemostatic factors Analysis of the Framingham Offspring Cohort. Circulation, 2001; 104: 1367–1373.
6. Menne LI, Balkau B, Vol S, Caces E, Eschwege E. Fibrinogen: a possible link between alcohol consumption and cardiovasular disease? DESIR Study Group. Arterioscler Thromb Vasc Biol 1999; 19: 887–892.
7. Gaziano JM, Hennekens CH, Godfried SL, et al Type of alcoholic beverage and risk of myocardial infarction. Am J Cardiol, 1999; 83: 52–57.
8. Gurtis G. Applied numerical analysis. California: Addison-Wesley Publishing Co.; 1978.
9. Rimm EB, Klatsky A, Grobbee D. Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine or spirits?. BMJ 1996; 321: 731–736.
10. Thun MJ, Peto R, Lopez AD, et al Alcohol consumption and mortality among middle-aged and elderly US adults. N Engl J Med, 1997; 337: 1705–1714.
11. Witteman JC, Willett WC, Stampfer MJ, et al Relation of moderate alcohol consumption and risk of systemic hypertension in women. Am J Cardiol, 1990; 65: 633–637.
12. Goldberg IJ, Mosca L, Piano M, Fisher E. Wine and your heart. A scientific advisory for healthcare professionals from the nutrition committee, council on epidemiology and prevention, and council on cardiovascular nursing of the American Heart Association. Circulation 2002; 103: 472–475.
13. Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C, Toutouzas PK. Risk stratification of coronary heart disease through established and emerging lifestyle factors, in a Mediterranean population: CARDIO2000 Epidemiological Study. J Cardiovasc Risk 2001; 8: 329–335.
14. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin or leucocyte count with coronary heart disease: metaanalyses of prospective studies. JAMA 1998; 279: 1477–1482.
15. Imhof A, Froehlich M, Brenner H, Boeing H, Pepys M, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 2001; 357: 763–767.
16. Danesh J, Whincup P, Walker M. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 2000; 321: 199–204.
17. Eikelboom JW, Lonn E, Genest J Jr, Hankley G, Yusuf S. Homocysteine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999; 131: 363–375.
18. Danesh J, Lewington S. Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J Cardiovasc Risk 1998; 5: 229–232.
19. Knekt P, Reunanen A, Alfthan G, Heliovaara M, Rissanen H, Marniemi J, Aromaa A. Hyperhomocysteinemia A risk factor or a concequenece of coronary heart disease. Arch Intern Med 2001; 161: 1589–1594.
20. Koehler KM, Baumgartner RN, Garry PJ, Allen RH, Stabler SP, Rimm EB. Association of folate intake and serum homocysteine in elderly persons according to vitamin supplementation and alcohol use. Am J Clin Nutr 2001; 73: 628–637.
21. Nygard O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 1998; 67: 263–270.
22. Hultberg G, Berglunt M, Andersson A, Frank A. Elevated plasma homocysteine in alcoholics. Alcohol Clin Exp Res 1993; 17: 687–689.
23. Halsted C. Lifestyle effects on homocysteine and an alcohol paradox. Am J Clin Nutr 2001; 73: 501–502.
24. Dudman NPB. An alternative view of homocysteine. Lancet 1999; 354: 2072–2074.
25. Rimm EB, Williams P, Fosher K, Criqui M, Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999; 319: 1523–1528.
26. Lamon-Fava S. High-density lipoproteins: effects of alcohol, estrogen, and phytoestrogens. Nutr Rev, 2002; 60(1):1–7.
27. Libby P. Inflammation and atherosclerosis. Circulation 2002; 105: 1135–1146.
28. Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999; 340: 115–126.
29. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease; meta-analysis of prospective studies. JAMA 1998; 279: 1477–1482.
30. Danesh J, Whincup P, Walker M, et al Low grade inflammation and coronary heart disease; prospective study and updated meta-analyses. BMJ, 2000; 321: 199–204.